Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy

International audience

Long-term consequences of Hodgkin lymphoma therapy on T-cell lymphopoiesis

International audience